GlassScriptPhysician profile
Todd George Lewis
NPI 1184802910
$843.92
in general payments reported to CMS, 2019-2025
15 companies · $261 in 2025
The $261 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.34 · 2020: $114 · 2021: $214 · 2022: $26.70 · 2023: $56.44 · 2024: $113 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $430.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $222.26 | 2021-2025 | Nuzyra |
| Stryker Corporation | $140.90 | 2024-2025 | Augment Injectable |
| Organogenesis INC. | $91.65 | 2021-2025 | Simplimax |
| Horizon Therapeutics Plc | $53.22 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $48.80 | 2019-2023 | Arazlo |
| Orthofix Medical, INC. | $47.21 | 2019-2021 | |
| Smith+Nephew, INC. | $46.50 | 2019-2021 | |
| Tactile Systems Technology INC | $37.29 | 2020 | |
| Depuy Synthes Sales INC. | $32.18 | 2025 | Motoband |
| Bioventus LLC | $30.62 | 2021 | |
| Pylant Medical | $29.00 | 2025 | |
| Genzyme Corporation | $23.75 | 2020 | |
| Abbott Laboratories | $17.01 | 2025 | Proclaim |
| Integra Lifesciences Corporation | $14.76 | 2021 | |
| Kerecis Limited | $8.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.